Followers | 246 |
Posts | 49771 |
Boards Moderated | 69 |
Alias Born | 08/29/2007 |
Wednesday, July 12, 2023 4:17:14 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent GDRX News
- Class Action Filed Against GoodRx Holdings, Inc. (GDRX) Seeking Recovery for Investors - Contact The Gross Law Firm • PR Newswire (US) • 05/03/2024 09:45:00 AM
- GoodRx Announces Date for 2024 Investor Day • Business Wire • 04/24/2024 12:00:00 PM
- GoodRx Announces Date for First Quarter 2024 Earnings Release and Conference Call • Business Wire • 04/11/2024 08:09:00 PM
- GoodRx Interim CEO Extends Commitment to Company • Business Wire • 03/14/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 10:15:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 10:14:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 10:20:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 12:00:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/01/2024 09:33:08 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/29/2024 07:37:11 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/29/2024 07:04:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 11:12:19 AM
- GoodRx Reports Fourth Quarter and Full Year 2023 Results • Business Wire • 02/29/2024 11:02:00 AM
- GoodRx to Participate in Upcoming Investor Conferences • Business Wire • 02/20/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 09:58:49 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 09:54:55 PM
- GoodRx Announces Date for Fourth Quarter and Full Year 2023 Earnings Release and Conference Call • Business Wire • 02/01/2024 09:05:00 PM
- GoodRx Announces Proposed Refinancing of First Lien Credit Facilities • Business Wire • 01/22/2024 07:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/17/2024 08:51:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/16/2024 10:00:56 PM
- The GoodRx Effect: Delivering a Transformative Impact on the U.S. Healthcare System through Prescription Savings • Business Wire • 01/11/2024 02:00:00 PM
- GoodRx Announces Preliminary Fourth Quarter and Full Year 2023 Results and Early Expectations for First Quarter and Full Year 2024 • Business Wire • 01/10/2024 02:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/10/2024 02:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/22/2023 02:06:27 PM
- GoodRx Appoints Kelly J. Kennedy to Board of Directors • Business Wire • 12/22/2023 02:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM